This analysis highlighted the potential central targets for HQGZWWD in DVT treatment, including AKT1 (degree = 51), IL6 (degree = 52), and IL1B (degree = 50) (Fig. 5). This evidence concerns the gene AKT1 and deep vein thrombosis.